Skip to main content

Counts and Characteristics of Pegylated Liposomal Doxorubicin and Non-Liposomal Doxorubicin Users: A Descriptive Analysis

    Basic Details
    Date Posted
    Medical Product
    non-liposomal doxorubicin
    pegylated liposomal doxorubicin

    In this report, we report counts and baseline characteristics of users of pegylated liposomal doxorubicin and its chosen comparator, non-liposomal doxorubicin, in the Sentinel Distributed Database (SDD). The study period includes data from January 1, 2011 to June 30, 2018. We distributed this request to 17 Sentinel Data Partners on September 26, 2018.

    Additional Details
    FDA Center
    Time Period
    January 1, 2011 - June 30, 2018
    Analysis Type
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)